Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04610476
What this trial is testing

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic ArthritisWithdrawalReduction
University of Erlangen-Nürnberg Medical School 270
Post-approval studies (Phase 4)Study completedNCT03406117
What this trial is testing

Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

Who this might be right for
HealthyAtopic DermatitisPsoriasis
Haus Bioceuticals 182
Early research (Phase 1)Looking for participantsNCT07363590
What this trial is testing

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Merck Sharp & Dohme LLC 21
Early research (Phase 1)Ended earlyNCT01649258
What this trial is testing

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Who this might be right for
Breast CancerNauseaVomiting
University of Southern California 29
Testing effectiveness (Phase 2)Looking for participantsNCT05837455
What this trial is testing

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Who this might be right for
Breast CancerCancer of the Breast
Washington University School of Medicine 81
Not applicableEnded earlyNCT03931655
What this trial is testing

Photoacoustic Lymph Node Imaging

Who this might be right for
Breast Cancer
Geoff Luke 1
Testing effectiveness (Phase 2)Study completedNCT00002826
What this trial is testing

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 36
Large-scale testing (Phase 3)Study completedNCT00560378
What this trial is testing

Long-term Safety of Protopic in Atopic Eczema

Who this might be right for
Dermatitis, AtopicEczema, Atopic
Astellas Pharma Inc 789
Not applicableStudy completedNCT01240278
What this trial is testing

Histology of Functional Density in Postmenopausal Breast

Who this might be right for
Dense BreastsBreast Cancer
Mayo Clinic 25
Not applicableStudy completedNCT01368835
What this trial is testing

Evaluation of the Ulthera™ System for Obtaining Lift and Tightening of the Cheek Tissue

Who this might be right for
Mild to Moderate Skin Laxity on CheekMild to Moderate Skin Laxity on Upper NeckMild to Moderate Subcutaneous Fat on Cheek+1 more
Ulthera, Inc 103
Not applicableUnknownNCT02516540
What this trial is testing

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer
Technical University of Munich 600
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Study completedNCT03823391
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 48
Not applicableStudy completedNCT00401297
What this trial is testing

Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes

Who this might be right for
Leishmaniasis
Yale University 122
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Not applicableStudy completedNCT05650060
What this trial is testing

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 163
Not applicableLooking for participantsNCT06680323
What this trial is testing

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

Who this might be right for
MelanomaSpitzoid MelanomaCongenital Nevi
University Hospital Tuebingen 200
Post-approval studies (Phase 4)Study completedNCT03098823
What this trial is testing

A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE

Who this might be right for
Lupus Erythematosus, SystemicLupus ErythematosusFatigue
Ampel BioSolutions, LLC 62
Not applicableStudy completedNCT06933225
What this trial is testing

Safety and Efficacy of a Microneedling Device Used in Facial Aesthetics

Who this might be right for
Skin Aging
Circa Skin Ltd 33
Not applicableStudy completedNCT05537350
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato

Who this might be right for
Skin
LycoRed Ltd. 66
Next Page